Cantabio Pharmaceuticals
2009
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
CTBO
STOCK SYMBOL
1
INVESTMENTS
$25.00
SHARE PRICE
(As of Thursday Closing)
Description
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.
Website
Formerly Known As
Gardedam Therapeutics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
- 2225 East Bayshore Road
- Palo Alto, CA 94303
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cantabio Pharmaceuticals’s full profile, request a free trial.
Cantabio Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $10.50 - $244.00 | $564K | $25.00 | -$200.00 | 60.41 | 22.5K |
Cantabio Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2018
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
FY 2016
31-Mar-2016
|
|---|---|---|---|---|
| Enterprise Value | 2,316 | 3,324 | 4,189 | 53,610 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (331) | (1,392) | (1,072) | (751) |
| Net Income | (1,543) | (2,012) | (1,112) | (751) |
| Total Assets | 326 | 109 | 34 | 52 |
| Total Debt | 1,409 | 1,205 | 369 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Cantabio Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Cantabio Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookCantabio Pharmaceuticals Competitors (20)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alector | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Framingham, MA | 0 | 0000 | 0000000000 0 | 0000 |
| 0000000 00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000 - 000 | 00000 |
| 0000000 | Venture Capital-Backed | Singapore, Singapore | 00 | 00000 | 0000000000 0 | 00000 |
Cantabio Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 0000000000 00 | 18-Dec-2015 | 000000000000000000 | Consulting Services (B2B) | 0000000 0ó00 00.0 |